Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2610-2617

  Diarra, M S ^a,b   Lavoie, M C ^c   Jacques, M ^b   Darwish, I ^d   Dolence, E K ^d   Dolence, J A ^d   Ghosh, A ^d   Ghosh, M ^d   Miller, M J ^d   Malouin, F ^a,e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF NOTRE DAME   (United States)

^e Microcide Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; COLICIN; DEFEROXAMINE; DEFEROXAMINE MESYLATE; ERYTHROMYCYLAMINE; FERRIC ION; FERRICHROME; LORACARBEF; NALIDIXIC ACID; OUTER MEMBRANE PROTEIN; SIDEROPHORE;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BORDETELLA BRONCHISEPTICA; DRUG CONJUGATION; ESCHERICHIA COLI; IRON TRANSPORT; MANNHEIMIA HAEMOLYTICA; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

EID: 10344230917     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2610     Document Type: Article

References (58)

1. Abdullah, K. H., E. A. Udoh, P. E. Shewen, and A. Melors. 1992. A natural glycoprotease of Pasteurella haemotytica A1 specifically cleaves O-sialoglycoproteins. Infect. Immun. 60:56-62.
2. Arends, J. P., and H. C. Zanem. 1988. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10:131-136.
3. Brochu, A., N. Brochn, T. I. Nicas, T. R. Parr, Jr., A. A. Minnick, Jr., E. K. Dolence, J. A. McKee, M. J. Miller, M. C. Lavoie, and F. Malouin. 1992. Modes of action and inhibitory activities of new siderophore-β-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Antimicrob. Agents Chemother. 36:2166-2175.
4. Braun, V., K. Gunthner, K. Hantke, and L. Zimmermann. 1983. Intracellular activation of albomycin in Escherichia coli and Salmonella typhymurium. J. Bacteriol. 156:308-315.
5. Braun, V., and K. Hantke. 1991. Genetics of bacterial iron transport, p. 107-138. In G. Winkelmann (ed.), Handbook of microbial iron chelates. CRC Press, Boston.
6. Carlone, G. M., M. L. Thomas, H. S. Rumschlag, and F. O. Sottnek. 1986. Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus influenzae. J. Clin. Microbiol. 24:330-332.
7. Crosa, J. H. 1989. Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol. Rev. 53:517-530.
8. Curtis, N. A. C., R. L. Eisenstadt, S. J. East, R. J. Cornford, L. A. Walker, and A. J. White. 1988. Iron-regulated outer membrane proteins of Escherichia coli K12 and mechanism of action of catechol-subslituted cephalosporins. Antimicrob. Agents Chemother. 32:1876-1886.
9. Deneer, H. G., and A. A. Potter. 1989. Effect of iron restriction on the outer membrane proteins of Actinobacillus (Haemophilus) pleuropneumoniae. Infect. Immun. 57:798-804.
10. 5-hydroxy-L-ornithine. J. Med. Chem. 34:956-968.
11. 5-hydroxy-L-ornithine derived siderophore-β-lactam conjugates: iron transport mediated drug delivery. J. Med. Chem. 34:968-978.
12. Fenwick, B. W., B. I. Osburn, and H. J. Olander. 1986. Isolation and biochemical characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae. Am. J. Vet. Res. 47:1433-1441.
13. Foster, L.-A. A., and D. Dyer. 1993. A siderophore production mutant of Bordetella bronchiseptica cannot use lactoferrin as an iron source. Infect. Immun. 61:2698-2702.
14. Gensberg, K., E. J. Doyle, D. J. Perry, and A. W. Smith. 1994. Uptake of BRL 41897A, a C(7) a-formamido substituted cephalosporin, via the ferripyochelin transport system of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 34:697-705.
15. Gentry, M. J., A. W. Confer, E. D. Weinberg, and J. T. Homer. 1986. Cytotoxin (leukotoxin) production by Pasteurella haemolytica: requirement for iron-containing compound. Am. J. Vet. Res. 47:1919-1923.
16. Gerlach, G. F., C. Anderson, A. A. Potter, A. Klashinsky, and P. J. Willson. 1992. Cloning and expression of a transferrin-binding protein from Actinobacillus pleuropneumoniae. Infect. Immun. 60:892-898.
17. Ghosh, A., M. Ghosh, F. Malouin, and M. J. Miller. Iron transport-mediated drug delivery. Synthesis and biological evaluation of spermidine-based mixed catechol and hydroxamate-containing siderophore-beta-lactam conjugates. Submitted for publication.
18. Ghosh, A., and M. J. Miller. 1993. Synthesis of novel citrate-based siderophores and siderophore-β-lactam conjugates. Iron transport-mediated drug delivery systems. J. Org. Chem. 58:7652-7659.
19. Ghosh, M., L. J. Lambert, P. W. Huber, and M. J. Miller. 1995. Synthesis, bioactivity, and DNA-cleaving ability of desferrioxamine β-nalidixic acid and anthraquinone carboxcylic acid conjugates. Bioorg. Med. Chem. Lett. 5: 2337-2340.
20. Ghosh, M., and M. J. Miller. 1994. Iron transport-mediated drug delivery: synthesis and biological evaluation of cyanuric acid-based siderophore analogs and β-lactam conjugates. J. Org. Chem. 59:1020-1026.
21. Ghosh, M., and M. J. Miller. 1995. Design, synthesis, and biological evaluation of isocyanaurate-based antifungal macrolide antibiotic conjugates: iron transport-mediated drug delivery. Bioorg. Med. Chem. 3:1519-1525.
22. Gonzalez, G. C., D. L. Caamano, and A. B. Schryvers. 1990. Identification and characterization of a porcine-specific transferrin receptor in Actinobacillus pleuropneumoniae. Mol. Microbiol. 4:1173-1179.
23. Higgins, R., and M. Gottschalk. 1989. L'infection à Streptococcus suis: une zoonose méconnue. Le medecin vétérinaire du Québec. 19:161-166.
24. Hu, S.-P., L. J. Felice, V. Sivanandan, and S. K. Maheswaran. 1986. Siderophore production by Pasteurella multocida. Infect. Immun. 54:804-810.
25. Klebba, P. E., J. M. Rutz, J. Liu, and C. K. Murphy. 1993. Mechanisms of TonB-catalyzed iron transport through the enteric bacterial cell envelope. J. Bioenerg. Biomembr. 25:603-611.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
27. Litwin, C. M., and S. B. Calderwood. 1993. Role of iron in regulation of virulence genes. Clin. Microbiol. Rev. 6:137-149.
28. Jacques, M., M. Bélanger, M. S. Diarra, M. Dargis, and F. Malouin. 1994. Modulation of Pasteurella multocida capsular polysaccharide during growth under iron-restricted conditions in vivo. Microbiology 140:263-270.
29. Martin, P. G., P. Lachance, and D. F. Niven. 1985. Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae. Can. J. Microbiol. 31:456-462.
30. McKee, J. A., and M. J. Miller. 1991. Synthesis, siderophore, and antimicrobial evaluation of a spermidine-based tricatecholate siderophore and carbacephalosporin conjugate. Bioorg. Med. Chem. Lett. 1:513-518.
31. McKee, J., S. K. Sharma, and M. J. Miller. 1991. Iron transport mediated drug delivery systems: synthesis and antibacterial activity of spermidine- and lysine-based siderophore-β-lactam conjugates. Bioconjugate Chem. 2:281-291.
32. Menozzi, F. D., C. Gantiez, and C. Locht. 1991. Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica. Infect. Immun. 59:3982-3988.
33. Miller, M. J., and F. Malouin. 1993. Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates. Acc. Chem. Res. 26:241-249.
34. Miller, M. J., and F. Malouin. 1994. Siderophore-mediated drug delivery: the design, synthesis and study of siderophore-antibiotic and antifungal conjugates, p. 275-306. In R. Bergeron (ed.), Microbial iron chelates. ch. 13. CRC Press, Boca Raton, Fla.
35. Miller, M. J., F. Malouin, E. K. Dolence, C. M. Gasparski, M. Ghosh, P. R. Guzzo, B. T. Lotz, J. A. McKee, A. A. Minnick, and M. Teng. 1993. Iron transport-mediated drug delivery, p. 135-159. In P. H. Bentley and R. Ponsford (ed.), Recent advances in the chemistry of anti-infective agents. Royal Society of Chemistry special publication no. 119. Royal Society of Chemistry, London.
36. Miller, M. J., J. A. McKee, A. A. Minnick, and E. K. Dolence. 1991. The design, synthesis and study of siderophore-antibiotic conjugates: siderophore mediated drug transport. Biol. Metals 4:62-69.
37. Minnick, A. A., J. A. Mckee, E. K. Dolence, and M. J. Miller. 1992. Iron transport-mediated activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates. Antimicrob. Agents Chemother. 36:840-850.
38. Mochizuki, H., H. Yamada, Y. Oikawa, H. Murakami, J. Ishiguro, H. Kosuzume, N. Aizawa, and E. Mochida. 1988. Bactericidal activity of M13659 enhanced in low-iron environments Antimicrob. Agents Chemother. 32: 1648-1654.
39. Nakagawa, S., M. Sanada, K. Marsuda, N. Hazumi, and N. Tanaka. 1987. Biological activity of BO-1236, a new antipseudomonal cephalosporin. Antimicrob. Agents Chemother. 31:1100-1115.
40. Neilands, J. B. 1981. Microbial iron compounds. Annu. Rev. Biochem. 50: 715-731.
41. Neilands, J. B., A. Bindereif, and J. Z. Montgomerie. 1985. Genetic basis of iron assimilation in pathogenic Escherichia coli. Curr. Top. Microbiol. Immunol. 118:179-195.
42. Nikaido, H., and E. Y. Rosenberg. 1990. Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with β-lactam antibiotics containing catechol and analogous groups. J. Bacteriol. 172:1361-1367.
43. Ogunnariwo, J. A., and A. B. Schryvers. 1990. Iron acquisition in Pasteurella haemolytica: expression and identification of a bovine-specific transferrin receptor. Infect. Immun. 58:2091-2097.
44. Ohi, N., B. Aoki, T. Shinozaki, K. Moro, T. Kuroki, T. Noto, T. Nehashi, M. Matsumoto, H. Okazaki, and I. Matsunaga. 1987. Semisynthetic β-lactam antibiotics. IV. Synthesis and antibacterial activity of new ureidocephalosporin and ureidocephamycin derivatives containing a catechol moiety or its acetate. Chem. Pharm. Bull. 35:1903-1909.
45. Ong, S. A., T. Peterson, and J. B. Neilands. 1976. Agrobactin, a siderophore from Agrobacterium tumefaciens. J. Biol. Chem. 254:1860-1865.
46. Parrot, M., P. W. Caufield, and M. C. Lavoie. 1989. Preliminary characterization of four bacteriocins from Streptococcus mutans. Can. J. Microbiol. 36:123-130.
47. Payne, S. M. 1993. Iron acquisition in microbial pathogenesis. Trends Microbiol. 1:66-69.
48. Postle, K. 1993. TonB protein and energy transduction between membranes. J. Bioenerg. Biomembr. 25:591-601.
49. Prelog, V. 1963. Iron-containing antibiotics and microbial growth factors. Pure Appl. Chem. 6:327.
50. Reissebrodt, R., W. Erler, and G. Winkelmann. 1994. Iron supply of Pasteurella multocida and Pasteurella haemolytica. J. Basic Microbiol. 34:K61-K63.
51. Rogers, H. J. 1973. Iron-binding catechols and virulence in Escherichia coli. Infect. Immun. 7:445-456.
52. Silver, S., and M. Walderhaug. 1992. Gene regulation of plasmid- and chromosome-determined inorganic ion transport in bacteria. Microbiol. Rev. 56:195-228.
53. Smith, P. W., A. J. Chamiec, G. Chung, K. N. Cobley, K. Duncan, P. D. Howes, A. R. Whittintong, and M. R. Wood. 1995. Synthesis and biological activity of novel cephalosporins containing a (Z)-vinyl dimethylphosphonate group. J. Antibiot. 48:73-82.
54. Trudel, L., M. Arriaga-Alba, and M. C. Lavoie. 1984. Survey of drug and phage resistance and colicin and hemolysin production among coliforms isolated in Ivory Coast. Appl. Environ. Microbiol. 48:905-907.
55. Watanabe, N.-A., T. Nagasu, K. Katsu, and K. Kitoh. 1987. E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrob. Agents Chemother. 31:497-504.
56. Wolfrey, B. F., and J. A. Moody. 1991. Human infections associated with Bordetella bronchiseptica. Clin. Microbiol. Rev. 4:243-255.
57. Wooldridge, K. G., and P. H. Williams. 1993. Iron uptake mechanism of pathogenic bacteria. FEMS Microbiol. Rev. 12:325-348.
58. Yates, W. D. G. 1982. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46:225-263.